These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36854083)

  • 1. Habits related to the use of insulin infusion set in patients with type 1 diabetes on pump therapy - the effect of the educational intervention.
    Ucieklak D; Mrozińska S; Wojnarska A; Małecki MT; Klupa T; Matejko B
    Folia Med Cracov; 2022 Dec; 62(4):5-23. PubMed ID: 36854083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily Life.
    Freckmann G; Arndt S; Fießelmann A; Klausmann G; Pralle K; Künsting T; Petersen B
    J Diabetes Sci Technol; 2017 Mar; 11(2):253-259. PubMed ID: 27605591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and Detection of Insulin Infusion Site Failure in the Type 1 Diabetes Exchange Online Community.
    Hughes MS; Douvas JL; Layfield-Bryan M; Blanco LE; Gray JC; Zapotoczny G; Espinoza J; Wilcox JH; Lal RA
    Diabetes Technol Ther; 2023 Jun; 25(6):426-430. PubMed ID: 36856574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Insulin Pump Infusion Sets Symposium Report.
    Zhang JY; Shang T; Chattaraj S; Cohen O; Heschel M; Vigersky RA; Heinemann L; Nørgaard K; Svensson J; Buckingham B; Klonoff DC
    J Diabetes Sci Technol; 2021 May; 15(3):705-709. PubMed ID: 33703930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin Infusion Set Use: European Perspectives and Recommendations.
    Deiss D; Adolfsson P; Alkemade-van Zomeren M; Bolli GB; Charpentier G; Cobelli C; Danne T; Girelli A; Mueller H; Verderese CA; Renard E
    Diabetes Technol Ther; 2016 Sep; 18(9):517-24. PubMed ID: 27526329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility study of a prototype extended-wear insulin infusion set in adults with type 1 diabetes.
    Kastner JR; Venkatesh N; Brown K; Muchmore DB; Ekinci E; Fourlanos S; Joseph JI; Shafeeq M; Shi L; Strange P; Strasma PJ; O'Neal DN
    Diabetes Obes Metab; 2022 Jun; 24(6):1143-1149. PubMed ID: 35257468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin infusion sets associated with adverse events: strategies for improved diabetes education.
    Neves ALD; Martins LEG; Gabbay MAL; Pascali P; de Oliveira T; Martinazzo A; Dib SA; Casarini DE; Aredes SV; Tenorio FS; Cunha TS
    Front Med (Lausanne); 2023; 10():1275394. PubMed ID: 38093983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Patient Experience With Insulin Infusion Sets: Practical Guidelines and Future Directions.
    Evert AB; Bode BW; Buckingham BA; Nardacci E; Verderese CA; Wolff-McDonagh P; Walsh J; Hirsch IB
    Diabetes Educ; 2016 Aug; 42(4):470-84. PubMed ID: 27056594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue Response to Subcutaneous Infusion Catheter.
    Zhang E; Cao Z
    J Diabetes Sci Technol; 2020 Mar; 14(2):226-232. PubMed ID: 30931603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin pump breakdown and infusion set failure in Italian children with type 1 diabetes: A 1-year prospective observational study with suggestions to minimize clinical impact.
    Rabbone I; Minuto N; Toni S; Lombardo F; Iafusco D; Marigliano M; Schiaffini R; Maltoni G; Frongia AP; Scardapane M; Nicolucci A; Cherubini V; Bonfanti R; Scaramuzza AE;
    Diabetes Obes Metab; 2018 Nov; 20(11):2551-2556. PubMed ID: 29893044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Lipohypertrophy in Patients With Type 1 Diabetes Mellitus on Multiple Daily Insulin Injections or Continuous Subcutaneous Insulin Infusion.
    Barlas T; Yalcin MM; Coskun M; Demirel D; Altinova AE; Toruner FB; Karakoc MA; Yetkin I; Akturk M
    Endocr Pract; 2023 Feb; 29(2):119-126. PubMed ID: 36423861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey.
    Pickup JC; Yemane N; Brackenridge A; Pender S
    Diabetes Technol Ther; 2014 Mar; 16(3):145-9. PubMed ID: 24180294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Insulin Injection and Infusion Routines on Lipohypertrophy and Glycemic Control in Children and Adults with Diabetes.
    Deeb A; Abdelrahman L; Tomy M; Suliman S; Akle M; Smith M; Strauss K
    Diabetes Ther; 2019 Feb; 10(1):259-267. PubMed ID: 30617932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic control after years of completing a clinical trial on sensor-augmented pump therapy.
    Quirós C; Giménez M; Orois A; Conget I
    Endocrinol Nutr; 2015 Nov; 62(9):447-50. PubMed ID: 26521155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the spectrum of depression and bipolarity in patients with type 1 diabetes.
    Cyranka K; Matejko B; Chrobak A; Dudek D; Kieć-Wilk B; Cyganek K; Witek P; Lushchyk M; Krzyżowska S; Małecki MT; Klupa T
    Diabetes Metab Res Rev; 2023 Jan; 39(1):e3583. PubMed ID: 36270020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
    Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C
    Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-induced Lipohypertrophy in Patients with Type 1 Diabetes Mellitus Treated with an Insulin Pump.
    Ucieklak D; Mrozinska S; Wojnarska A; Malecki MT; Klupa T; Matejko B
    Int J Endocrinol; 2022; 2022():9169296. PubMed ID: 35111222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
    Diabetes Care; 2015 Apr; 38(4):716-22. PubMed ID: 25776138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bridge to insulin pump therapy: twice-daily regimen with NPH and detemir insulins during initial treatment of youth with type 1 diabetes mellitus.
    Cengiz E; Sherr JL; Erkin-Cakmak A; Weinzimer SA; Burke EN; Sikes KA; Urban AD; Tamborlane WV
    Endocr Pract; 2011; 17(6):862-6. PubMed ID: 21550949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
    Diabetologia; 2015 May; 58(5):862-70. PubMed ID: 25784563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.